Hospitals that serve the more vulnerable population perform worse with their readmission rate following cancer surgery, and the subsequent penalties that they face can further strain the hospital’s already burdened finances.
Hospitals that serve the more vulnerable population perform worse with their readmission rate, and the subsequent penalties that they face can further strain the hospital’s already burdened finances. These are the conclusions from a new study, published online in the Journal of the American College of Surgeons, which evaluated the readmission rate in patients following cancer surgery.
Nearly 110,900 patients who underwent complex surgeries for their cancer—between January 1, 2004, and September 30, 2011, in California—were identified. Vulnerable hospitals were defined as either self-identified safety net hospitals (SNH) or hospitals with high percentage of Medicaid patients (high Medicaid hospitals, HMH). Of the 355 hospitals that were included in the analysis, 13 were SNH and 31 were HMH. After adjusting for Hospital Readmissions Reduction Program (HRRP) variables, the study found that:
Further, with respect to patient demographics, patients who were admitted for surgeries in vulnerable hospitals, compared with non-vulnerable hospitals, were:
Additionally, HMH hospitals saw a significantly greater number of patients of Hispanic origin enrolled.
While multiple factors can influence readmission rates, socioeconomic and hospital characteristics bear significant weight. Penalizing hospitals for high readmission rates without understanding these influences can add significant stress on a hospital’s resources. A report released by Kaiser Health News last year found that following inception of the HRRP, readmission rates dropped overall, but 1 in 5 hospitalized Medicare patients were still readmitted to the hospital within 30 days. These numbers underscore the vulnerable nature of hospitals that serve these patients.
“Different hospitals have different patient mixes, and if that is not factored in, HRRP reductions in payment may further marginalize financially vulnerable hospitals,” said corresponding study author Waddah B. Al-Refaie, MD, FACS, chief of surgical oncology, MedStar Georgetown University Hospital, in a press release.
Reference
Hong Y, Zheng C, Hechenbleikner E, et al. Vulnerable hospitals and cancer surgery readmissions: Insights into the unintended consequences of the Patient Protection and Affordable Care Act [published online May 31, 2016]. J Am Coll Surg. doi:http://dx.doi.org/10.1016/j.jamcollsurg.2016.04.042.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More